ScreenerHero
GDRgenedrive plc
LSE · GB · Healthcare · Diagnostics & Research · genedriveplc.com
1.350GBP+8.00%Mkt Cap: 27.80M $P/E: —

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The co…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap27.80M $
Enterprise Value17.97M $
Revenue (TTM)1.51M $
Gross Profit-4.28M $
Net Income (TTM)-6.71M $
Revenue/Share0.0026 USD
Last Price1.350 GBP
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees43
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.01
PEG—
EV/EBITDA-2.60
EV/Revenue11.94
P/S18.19
P/B—
EPS (TTM)-0.01
EPS (Forward)2.10
52W Range
0.190092% of range1.450
52W High1.450 GBP
52W Low0.1900 GBP
Profitability
Gross Margin-283.99%
Oper. Margin-459.47%
EBITDA Margin0.00%
Profit Margin-684.69%
ROE-363.77%
ROA-185.83%
Growth
Revenue Growth62.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.60M $
CapEx (TTM)29.50K $
FCF Margin-173.52%
FCF Yield-9.40%
Net Debt144.93K $
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.00
Current Ratio0.99
Quick Ratio0.78
Book Value/Sh0.0000 GBP
Cash/Share0.0000 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.61B
Float561.10M
Insiders63.50%
Institutions1.31%
Technical
SMA 501.183 (+14.2%)
SMA 2001.053 (+28.2%)
Beta0.97
S&P 52W Chg18.16%
Avg Vol (30d)4.69M
Avg Vol (10d)3.12M
Technical Indicators
RSI (14)68.5
MACD0.0343
MACD Signal0.0053
MACD Hist.+0.0290
BB Upper1.333 GBP
BB Middle1.123 GBP
BB Lower0.9131 GBP
BB Width37.39%
ATR (14)0.1159 GBP
Vol Ratio (20d)1.35x